Viagra has revolutionized the treatment of erectile dysfunction (ED) and ED market, after its launch in 1998. But due to its side effects, new treatments are under development. It is estimated that new therapies will drive overall product sales in major pharmaceutical markets to US$3.6 B in 2011. This article focuses on the significant unmet clinical need that remains in the ED market and a high prevalence of ED.